<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04604561</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-20335</org_study_id>
    <nct_id>NCT04604561</nct_id>
  </id_info>
  <brief_title>Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses</brief_title>
  <official_title>Physician Initiated Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Elucent Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>H. Lee Moffitt Cancer Center and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to estimate the success of the SmartClip device for accurate placement&#xD;
      and reproducibility of intraoperative identification of in-breast lesions and for excision&#xD;
      utilizing surgical navigation indicators.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 27, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ability of localizing in-breast lesions using the Envisio Navigation and SmartClip system in surgery - Radiologist Cohort</measure>
    <time_frame>1 year</time_frame>
    <description>Questions 1,2,5,6,7 &amp; 8 from the Radiologist survey will evaluate the EnVisio system for reproducible in-breast tumor localization by the performing physicians.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ability of localizing in-breast lesions using the Envisio Navigation and SmartClip system in surgery - Surgeon Cohort</measure>
    <time_frame>1 year</time_frame>
    <description>Questions 4, 5, 6, 8, 9, 10, &amp; 11 from the Surgeon survey will evaluate the EnVisio system for reproducible in-breast tumor localization by the performing physicians.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Placement of the SmartClip on preoperative imaging to clip location on specimen radiography</measure>
    <time_frame>1 year</time_frame>
    <description>Radiologists will take radiologist questionnaire evaluating their experience using the SmartClip</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Placement and visibility of the clip by breast radiologists</measure>
    <time_frame>1 year</time_frame>
    <description>Radiologists will take radiologist questionnaire evaluating their experience using the SmartClip</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative use of the device system by surgeons</measure>
    <time_frame>1 year</time_frame>
    <description>Surgeons will take surgeon questionnaire evaluating their experience using the SmartClip and EnVisio™ Navigation System</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical outcomes with use of the SmartClip</measure>
    <time_frame>1 year</time_frame>
    <description>Surgeons will take surgeon questionnaire evaluating their experience using the SmartClip and EnVisio™ Navigation System</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Participants receiving SmartClip</arm_group_label>
    <description>Participants will undergo a preoperative physical exam and at least one preoperative ultrasound demonstrating the mass for resection. The SmartClip will be placed under ultrasound guidance. Post-placement mammogram will be obtained after placement of the clip. The SmartClip can be placed up to 30 days prior to the planned surgical resection. At the time of definitive surgery, the Envisio system will be used to identify the clip and the targeted lesion for resection. Intraoperatively, a specimen radiograph will be performed to confirm the presence of the SmartClip and the targeted lesion in the surgical specimen. The breast surgical specimen will be sent for gross examination, including measurements of the tumor in 3 axes. Immediately post-procedure, the performing surgeon will fill out a questionnaire to determine the ability of localizing in-breast lesions using the Envisio Navigation and SmartClip system in surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiologist Placing SmartClip</arm_group_label>
    <description>Radiologist will place SmartClip under ultrasound guidance. A Post-placement mammogram will be obtained after placement of the SmartClip. Immediately post-procedure, the performing radiologist will fill out a questionnaire.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgeon</arm_group_label>
    <description>The surgeon will use the EnVisio™ Navigation System to identify the SmartClip and the targeted lesion for resection. Immediately post-procedure, the performing surgeon will fill out a questionnaire</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EnVisio SmartClip</intervention_name>
    <description>The Envisio SmartClip is an FDA-cleared (approved) device for localization of in-breast lesions. While using The EnVisio™ Navigation System, the system will detect the presence of the SmartClip™ Soft Tissue Marker(s) and provide real-time three-dimensional navigation during the surgery.</description>
    <arm_group_label>Participants receiving SmartClip</arm_group_label>
    <arm_group_label>Radiologist Placing SmartClip</arm_group_label>
    <arm_group_label>Surgeon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EnVisio™ Navigation System</intervention_name>
    <description>The EnVisio™ Navigation System acquires and analyzes electromagnetic signatures that display the relative distance, depth, and direction from the tip of the electrosurgical tool to the implanted SmartClipTM(s) within the surgeon's field of view during the procedure.</description>
    <arm_group_label>Participants receiving SmartClip</arm_group_label>
    <arm_group_label>Radiologist Placing SmartClip</arm_group_label>
    <arm_group_label>Surgeon</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited to this study from the Moffitt Cancer Center Comprehensive&#xD;
        Breast Clinic. Patients are seen in this clinic by breast surgeons from the Comprehensive&#xD;
        Breast Program at Moffitt Cancer Center.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants must have a sonographically identifiable in-breast lesion measuring at&#xD;
             least 15mm on ultrasound imaging and consent to undergo a surgical resection using the&#xD;
             SmartClip localization system at the McKinley operative suites at Moffitt Cancer&#xD;
             Center&#xD;
&#xD;
          -  Participants must be age &gt; or = 18 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants with sonographically occult target lesions&#xD;
&#xD;
          -  Participants with greater than 35cm chest to bust depth&#xD;
&#xD;
          -  Participants undergoing mastectomy for resection of the targeted lesion&#xD;
&#xD;
          -  Inability to undergo surgery at the McKinley OR suites due to institutional anesthesia&#xD;
             guidelines&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M. Catherine Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moffitt Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Delilah Ponce</last_name>
    <phone>813-745-7964</phone>
    <email>Delilah.Ponce@moffitt.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Catherine Lee, MD</last_name>
      <phone>813-745-3512</phone>
      <phone_ext>8373</phone_ext>
      <email>M.Catherine.Lee@moffitt.org</email>
    </contact>
    <contact_backup>
      <last_name>Delilah Ponce</last_name>
      <phone>813-745-7964</phone>
      <email>Delilah.Ponce@moffitt.org</email>
    </contact_backup>
    <investigator>
      <last_name>Alec Chau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angela Williams, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bethany Niell, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Blaise Mooney, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Czerniecki, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Gonzalez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christine Laronga, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dana Ataya, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Boulware, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jared Weinfurtner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John V Kiluk, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kimberly Funaro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nazanin Khakpour, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shannon Falcon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan Hoover, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://moffitt.org/clinical-trials-research/clinical-trials/</url>
    <description>Moffitt Cancer Center Clinical Trial Search</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 9, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2020</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SmartClip</keyword>
  <keyword>EnVisio™ Navigation System</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

